Bladder Cancer Trials

RTOG 0926

RTOG 0926:  A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following A Thorough Transurethral Surgical Re-staging

Purpose

This trial is studying how well radiation therapy given together with chemotherapy works in treating patients with stage I bladder cancer.

Eligibilty:

This study is looking for patients with T1 high grade bladder cancer who are surgical candidates.

Learn more about this study.

For more information, call (260) 425-6800 and ask to speak to a clinical research coordinator. You may also e-mail oncologyresearch@parkview.com.

Parkview Cancer Institute
11050 Parkview Circle
Fort Wayne, Indiana 46845

Search By Cancer Type

 

Need assistance?

Contact us